Coenzyme Q10 in heart failure: Q-SYMBIO
CoQ10 reduced major adverse cardiovascular events by 43% and all-cause mortality by 42% vs placebo in patients with chronic heart failure.
CoQ10 (and its reduced form ubiquinol) is essential for mitochondrial ATP production. Levels decline with age and are depleted by statins. Strongest evidence: heart failure, statin-associated muscle pain, migraine prevention.
CoQ10 reduced major adverse cardiovascular events by 43% and all-cause mortality by 42% vs placebo in patients with chronic heart failure.
CoQ10 supplementation produced significant reductions in statin-associated muscle pain, weakness, cramps, and tiredness vs placebo.
CoQ10 reduced migraine frequency by 50%+ in significantly more patients than placebo (47% vs 14%).
We prioritize randomised controlled trials and meta-analyses over single observational studies. Animal and in-vitro data are listed as "mechanistic", they suggest direction, not human effect size.
We don't cherry-pick favourable studies, omit conflicting evidence, or cite industry-funded trials without flagging the conflict of interest where known.
The research is one thing, what to take, at what dose, paired with what, is another. We compose stacks that turn the evidence into a daily routine.
Studies referenced are real published research. Summaries are paraphrased for accessibility, for exact methods and full text, click through to PubMed. Educational use only, not medical advice. Consult a qualified clinician before starting any new supplement.